Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,955 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation.
Harada K, Fuji S, Seo S, Kanda J, Ueki T, Kimura F, Kato K, Uchida N, Ikegame K, Onizuka M, Matsuoka KI, Doki N, Kawakita T, Onishi Y, Yano S, Fukuda T, Takanashi M, Kanda Y, Atsuta Y, Ogata M; transplant complications working group of the Japan Society for Hematopoietic Cell Transplantation. Harada K, et al. Bone Marrow Transplant. 2020 Sep;55(9):1784-1795. doi: 10.1038/s41409-020-0821-9. Epub 2020 Feb 12. Bone Marrow Transplant. 2020. PMID: 32051535
Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.
Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Watanabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Ikegawa S, et al. Among authors: harada k. Leuk Lymphoma. 2016;57(1):76-80. doi: 10.3109/10428194.2015.1063148. Leuk Lymphoma. 2016. PMID: 26084204
CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission.
Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Hattori K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K. Ikegawa S, et al. Among authors: harada k. Leuk Lymphoma. 2016;57(6):1375-81. doi: 10.3109/10428194.2015.1099644. Epub 2015 Dec 23. Leuk Lymphoma. 2016. PMID: 26422713
Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease.
Harada K, Kurosawa S, Hino Y, Yamamoto K, Sakaguchi M, Ikegawa S, Hattori K, Igarashi A, Watakabe K, Senoo Y, Najima Y, Hagino T, Doki N, Kobayashi T, Kakihana K, Iino T, Sakamaki H, Ohashi K. Harada K, et al. Springerplus. 2016 Apr 23;5:512. doi: 10.1186/s40064-016-2161-1. eCollection 2016. Springerplus. 2016. PMID: 27186476 Free PMC article.
[Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation].
Hino Y, Doki N, Yamamoto K, Senoo Y, Sasajima S, Sakaguchi M, Hattori K, Kaito S, Kurosawa S, Harada K, Ikegawa S, Watanabe D, Hagino T, Yoshioka K, Watakabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Hino Y, et al. Among authors: harada k. Rinsho Ketsueki. 2016 May;57(5):608-12. doi: 10.11406/rinketsu.57.608. Rinsho Ketsueki. 2016. PMID: 27263786 Japanese.
Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.
Harada K, Yamada Y, Konishi T, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Yasuda S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Hagino T, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K. Harada K, et al. Int J Hematol. 2016 Dec;104(6):709-719. doi: 10.1007/s12185-016-2085-0. Epub 2016 Aug 26. Int J Hematol. 2016. PMID: 27565504
Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Hattori K, Doki N, Kurosawa S, Hino Y, Yamamoto K, Sakaguchi M, Harada K, Ikegawa S, Shingai N, Senoo Y, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Hattori K, et al. Among authors: harada k. Ann Hematol. 2017 Feb;96(2):319-321. doi: 10.1007/s00277-016-2854-0. Epub 2016 Oct 21. Ann Hematol. 2017. PMID: 27766393 No abstract available.
[Donor cell leukemia with bone marrow necrosis].
Ikegawa S, Najima Y, Sano N, Horiguchi SI, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Hino Y, Yamamoto K, Senoo Y, Watanabe D, Yoshioka K, Watakabe K, Igarashi A, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Hishima T, Ohashi K. Ikegawa S, et al. Among authors: harada k. Rinsho Ketsueki. 2016;57(11):2334-2338. doi: 10.11406/rinketsu.57.2334. Rinsho Ketsueki. 2016. PMID: 27941282 Japanese.
Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.
Ikegawa S, Doki N, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Watanabe D, Hagino T, Yoshioka K, Watakabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Ikegawa S, et al. Among authors: harada k. Pathol Oncol Res. 2017 Apr;23(2):433-437. doi: 10.1007/s12253-016-0162-6. Epub 2016 Dec 21. Pathol Oncol Res. 2017. PMID: 28004352 Free article.
Erythrocytosis after allogeneic hematopoietic stem cell transplantation.
Hino Y, Doki N, Kurosawa S, Yamamoto K, Sakaguchi M, Harada K, Ikegawa S, Shingai N, Hattori K, Senoo Y, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Hino Y, et al. Among authors: harada k. Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12918. Epub 2017 Feb 28. Clin Transplant. 2017. PMID: 28247439 No abstract available.
4,955 results